4D Molecular Therapeutics
FDMT
FDMT
64 hedge funds and large institutions have $665M invested in 4D Molecular Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+12
Holders Change %
+23.08%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
28
Increased
13
Reduced
13
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$23.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$19M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
$13.1M |
| 4 |
LCM
Laurion Capital Management
New York
|
$12M |
| 5 |
CC
Casdin Capital
New York
|
$43.2M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EGM
76
Engineers Gate Manager
New York
| – | -$337K | -8,139 | Closed |
|
|
MS
77
Maven Securities
St Helier,
Jersey
| – | -$271K | -6,500 | Closed |
|
|
SAM
78
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$217K | -5,224 | Closed |
|
79
Norges Bank
Oslo,
Norway
| – | -$207K | -5,000 | Closed |
|
|
DKCM
80
Davidson Kempner Capital Management
New York
| – | -$124K | -3,000 | Closed |
|